FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Dual 510(k) CLIA Waiver Guidance

[ Price : $8.95]

FDA issues a draft guidance leveraging its experience in implementing the MDUFA 3 Dual 5120(k) and CLIA Waiver by Application path...

CGMP Violations at Koreas Dae Young Foods

[ Price : $8.95]

FDA warns South Koreas Dae Young Foods Company about CGMP and misbranding violations in its work as a contractor manufacturing fin...

Sentinel Role in Drug Safety Defended

[ Price : $8.95]

CDER Office of Surveillance and Epidemiology deputy director Robert Ball describes the ways in which the agencys Sentinel System i...

FDA Has Most of HHS Withdrawn Regulations: Survey

[ Price : $8.95]

A Public Citizen analysis of 457 rulemakings withdrawn by the Trump administration finds that 26 were from FDA, the highest number...

Draft Guide on CLIA Waivers

[ Price : $8.95]

FDA posts a draft guidance on Select Updates for Recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA) Wai...

FDA Adds Patent Submission Dates to Orange Book

[ Price : $8.95]

Two Hyman, Phelps attorneys say FDA is helping generic drug applicants by starting to list patent submission dates in the Orange B...

FDA Guide on Pediatric Info in X-ray 510(k)s

[ Price : $8.95]

Federal Register notice: FDA makes available a guidance entitled Pediatric Information for X-ray Imaging Device Premarket Notifica...

FDA Reducing Hurdles for Generic Complex Drugs: Gottlieb

[ Price : $8.95]

Commissioner Scott Gottlieb says FDA ramps up its efforts to improve the process for developing generic copies of complex drugs.

Safety Alert on Biotin Affecting Lab Testing

[ Price : $8.95]

An FDA safety alert warns that dietary supplements containing biotin (vitamin B7) can cause clinically significant incorrect lab t...

Latest FDA Warning Letters

[ Price : $8.95]

FDA releases its latest batch of Warning Letters that includes Dae Young Foods Co. and JMA Partners, Inc.